These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29168760)

  • 61. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mesenchymal stem cells in kidney inflammation and repair.
    Wise AF; Ricardo SD
    Nephrology (Carlton); 2012 Jan; 17(1):1-10. PubMed ID: 21777348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels.
    Guerra AD; Rose WE; Hematti P; Kao WJ
    Acta Biomater; 2017 Mar; 51():184-196. PubMed ID: 28069512
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intracellular co-delivery of Sr ion and phenamil drug through mesoporous bioglass nanocarriers synergizes BMP signaling and tissue mineralization.
    Lee JH; Mandakhbayar N; El-Fiqi A; Kim HW
    Acta Biomater; 2017 Sep; 60():93-108. PubMed ID: 28713017
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characteristics, applications and prospects of mesenchymal stem cells in cell therapy.
    Guadix JA; Zugaza JL; Gálvez-Martín P
    Med Clin (Barc); 2017 May; 148(9):408-414. PubMed ID: 28126234
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesenchymal Stromal Cells to Regenerate Emphysema: On the Horizon?
    Kruk DMLW; Heijink IH; Slebos DJ; Timens W; Ten Hacken NH
    Respiration; 2018; 96(2):148-158. PubMed ID: 29719298
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brief Report: Elastin Microfibril Interface 1 and Integrin-Linked Protein Kinase Are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal Cells.
    Lavoie JR; Creskey MM; Muradia G; Bell GI; Sherman SE; Gao J; Stewart DJ; Cyr TD; Hess DA; Rosu-Myles M
    Stem Cells; 2016 Aug; 34(8):2249-55. PubMed ID: 27090767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.
    Cipriani P; Ruscitti P; Di Benedetto P; Carubbi F; Liakouli V; Berardicurti O; Ciccia F; Triolo G; Giacomelli R
    Cytotherapy; 2015 Jul; 17(7):832-49. PubMed ID: 25680301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Mesenchymal stromal cells: Biological properties and clinical prospects].
    Roux S; Leotot J; Chevallier N; Bierling P; Rouard H
    Transfus Clin Biol; 2011 Feb; 18(1):1-12. PubMed ID: 21367635
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
    Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
    Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.
    Noronha NC; Mizukami A; Caliári-Oliveira C; Cominal JG; Rocha JLM; Covas DT; Swiech K; Malmegrim KCR
    Stem Cell Res Ther; 2019 May; 10(1):131. PubMed ID: 31046833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery.
    Almeida-Porada G; Atala AJ; Porada CD
    Mol Ther Methods Clin Dev; 2020 Mar; 16():204-224. PubMed ID: 32071924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Nonenzymatic and Automated Closed-Cycle Process for the Isolation of Mesenchymal Stromal Cells in Drug Delivery Applications.
    Coccè V; Brini A; Giannì AB; Sordi V; Berenzi A; Alessandri G; Tremolada C; Versari S; Bosetto A; Pessina A
    Stem Cells Int; 2018; 2018():4098140. PubMed ID: 29531535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current and Future Perspectives of Stem Cell Therapy in Dermatology.
    Prodinger CM; Reichelt J; Bauer JW; Laimer M
    Ann Dermatol; 2017 Dec; 29(6):667-687. PubMed ID: 29200755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery.
    Hochheuser C; Kunze NY; Tytgat GAM; Voermans C; Timmerman I
    J Pers Med; 2021 Feb; 11(3):. PubMed ID: 33668854
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach.
    Adjei IM; Blanka S
    J Funct Biomater; 2015 Feb; 6(1):81-103. PubMed ID: 25695337
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New perspectives for mesenchymal stromal cells as an adjuvant therapy for infectious disease-associated encephalopathies.
    Lima MN; Barbosa-Silva MC; Maron-Gutierrez T
    Neural Regen Res; 2022 Jan; 17(1):48-52. PubMed ID: 34100426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correction to: Skin regeneration is accelerated by a lower dose of multipotent mesenchymal stromal/ stem cells-a paradigm change.
    Eylert G; Dolp R; Parousis A; Cheng R; Auger C; Holter M; Lang-Olip I; Reiner V; Kamolz LP; Jeschke MG
    Stem Cell Res Ther; 2021 Apr; 12(1):256. PubMed ID: 33931114
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.